- Home
- MDXG vs RXST Comparison
MDXG vs RXST Comparison
Compare MDXG & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- RXST
- Stock Information
- Founded
- MDXG 2006
- RXST 1997
- Country
- MDXG United States
- RXST United States
- Employees
- MDXG N/A
- RXST N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MDXG Health Care
- RXST Health Care
- Exchange
- MDXG Nasdaq
- RXST Nasdaq
- Market Cap
- MDXG 1.0B
- RXST 1.0B
- IPO Year
- MDXG N/A
- RXST 2021
- Fundamental
- Price
- MDXG $7.25
- RXST $13.75
- Analyst Decision
- MDXG Strong Buy
- RXST Buy
- Analyst Count
- MDXG 3
- RXST 10
- Target Price
- MDXG $12.00
- RXST $38.50
- AVG Volume (30 Days)
- MDXG 815.1K
- RXST 1.2M
- Earning Date
- MDXG 04-30-2025
- RXST 05-07-2025
- Dividend Yield
- MDXG N/A
- RXST N/A
- EPS Growth
- MDXG N/A
- RXST N/A
- EPS
- MDXG 0.27
- RXST N/A
- Revenue
- MDXG $352,375,000.00
- RXST $148,310,000.00
- Revenue This Year
- MDXG $9.23
- RXST $24.14
- Revenue Next Year
- MDXG $11.49
- RXST $21.47
- P/E Ratio
- MDXG $26.71
- RXST N/A
- Revenue Growth
- MDXG 5.34
- RXST 46.70
- 52 Week Low
- MDXG $5.47
- RXST $13.50
- 52 Week High
- MDXG $10.14
- RXST $66.54
- Technical
- Relative Strength Index (RSI)
- MDXG 54.99
- RXST 37.14
- Support Level
- MDXG $6.53
- RXST $13.03
- Resistance Level
- MDXG $7.52
- RXST $15.41
- Average True Range (ATR)
- MDXG 0.34
- RXST 0.93
- MACD
- MDXG 0.11
- RXST 0.28
- Stochastic Oscillator
- MDXG 81.63
- RXST 24.04
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.